tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market

PharmAla Biotech Holdings, Inc. (MDMA) Income Statement

Compare
57 Followers

PharmAla Biotech Holdings, Inc. Income Statement

Last quarter (Q1 2025), PharmAla Biotech Holdings, Inc.'s total revenue was C$57.30K, a decrease of -86.94% from the same quarter last year. In Q1, PharmAla Biotech Holdings, Inc.'s net income was C$-479.11K. See PharmAla Biotech Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21
Total Revenue
C$ 1.04MC$ 532.00KC$ 78.07KC$ 0.00
Gross Profit
C$ 887.44KC$ 454.10KC$ 75.78KC$ -303.00
Operating Expenses
C$ 887.44KC$ 1.22MC$ 1.06MC$ 2.51M
Depreciation and Amortization
C$ 70.21KC$ 52.77KC$ 12.13KC$ 303.00
EBITDA
C$ -573.36KC$ -710.18KC$ -973.45KC$ -2.51M
Operating Income
C$ 0.00C$ -762.95KC$ -985.58KC$ -2.51M
Other Income/Expenses
C$ -823.60KC$ -16.86KC$ 0.00C$ 0.00
Pretax Income
C$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Net Income
C$ -823.60KC$ -779.81KC$ -985.58KC$ -2.51M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Diluted EPS
C$ -0.01C$ -0.01C$ -0.01C$ -0.03
Weighted Average Shares Outstanding
88.57M 84.53M 83.00M 83.00M
Weighted Average Shares Outstanding (Diluted)
88.57M 84.53M 83.00M 83.00M
Currency in CAD

PharmAla Biotech Holdings, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis